OTC paternity test kit available at Rite Aid
SALT LAKE CITY Identigene on Tuesday announced that its Identigene DNA Paternity Test Collection Kit is now available for over-the-counter purchase at all Rite Aid drug stores throughout the U.S., with the exception of stores in New York.
The Identigene DNA Paternity Test Collection Kit was the first DNA test ever sold in retail stores when it was offered on a trial basis beginning November 2007 in California, Washington and Oregon. According to the company, initial demand has been very strong.
“Over-the-counter sales offers a completely new marketing channel for DNA testing,” stated Doug Fogg, chief operating officer of Identigene. “We learned that people are extremely receptive to the idea of purchasing a DNA paternity test kit while shopping at one of the nation’s leading drug store chains.”
Outside New York state, Rite Aid has 4,363 stores in 30 states and the District of Columbia. Fogg said he anticipates the Identigene DNA Paternity Test Collection Kits will be sold in New York state at a later date.
Suggested retail price for an Identigene DNA Paternity Test Collection Kit is $29.99, and the laboratory processing fee is $119.
Intlekofer resigns at Nutrition 21
PURCHASE, N.Y. Nutrition 21 on Friday announced that Paul Intlekofer has resigned as chief executive officer and as a director of the company.
“We thank Paul for the many years of service that he has given to the company, and appreciate his desire to work in the vicinity of his home in Baltimore,” stated John Gutfreund, the company’s chairman. “He will serve as a consultant to the company.”
Gerard Butler and Michael Fink have been elected to serve as interim co-chief executive officers.
Both Butler and Fink were previously executives at Prestige Brands Holdings and Block Drug Company.
FDA launches updated Web site
ROCKVILLE, Md. The Food and Drug Administration this week unveiled a new Web site—a Web site that features a “layered” approach that enables FDA surfers to find information quickly.
“Structure is improved to provide for easy scanning; content is presented in plain language to make it more understandable,” the FDA stated in introducing the new Web format. “In a nutshell, we listened to you. We tested the usability of our Web site by asking our key audiences. We sampled more than 188 consumers, healthcare professionals and industry representatives and other audiences. … This usability data pointed us to improvements to make the home page easier and more satisfying to use.”